Neus Domper
Director Clinical Development, Clinical Scientist at ADC Therapeutics | Neuchâtel, Neuchâtel, Switzerland
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Neus Domper currently serves as the Director of Clinical Development and Clinical Scientist at ADC Therapeutics, where she plays a pivotal role in advancing innovative oncology therapies. In her leadership capacity, Neus oversees the strategic planning and execution of clinical trials, ensuring alignment with regulatory standards and company objectives. Her expertise in early and late-phase clinical development is instrumental in driving the successful progression of ADC Therapeutics’ pipeline, particularly in the development of antibody-drug conjugates (ADCs) like ZYNLONTA (Loncastuximab tesirine).
Neus’s extensive background in pharmacology and her 20+ years of experience in the pharmaceutical industry enable her to effectively manage complex clinical projects, from protocol development to site management and data analysis. Her proficiency in clinical trial management systems (CTMS), CRO collaboration, and SOP implementation ensures seamless execution of clinical studies, while her deep understanding of oncology, hematology, and targeted therapies supports the development of personalized treatment options.
Key projects under her leadership include the design and oversight of pivotal trials for ADCs, where her expertise in medical affairs and HEOR provides valuable insights into the clinical and economic value of novel therapies. Neus’s strategic approach combines scientific rigor with project management skills, facilitating the translation of innovative research into tangible patient benefits. Her role exemplifies a commitment to advancing oncology treatment options through meticulous clinical development, fostering collaborations across multidisciplinary teams, and maintaining a focus on regulatory compliance and data integrity.
Director Clinical Development, Clinical Scientist at ADC Therapeutics in March 2024 to Present
Director, Clinical Development, Clinical Science at Kite Pharma in May 2022 to February 2024
Associate Director, Senior Clinical Scientist, Lymphoma and Multiple Myeloma Cell Therapy at Celgene in September 2017 to May 2022
Expert Clinical Manager, Oncology Global Drug Development at Novartis in July 2013 to August 2017
Clinical Trial Manager at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company in February 2009 to December 2012
HEOR Oncology Specialist - Project Manager at IMS Health in January 2007 to January 2008
Medical Affairs, IST Advocate / Clinical Development, Associate Clinical Study Manager at Merck KGaA in January 2003 to January 2007
See more
See less
Universitat Pompeu Fabra, Farmacoeconomia y Economía de la Salud, October 2026
Universitat de Barcelona, Monitorización de Ensayos Clínicos, October 2026
Universitat de Barcelona, Farmacia, October 1995 to October 2026
See more
See less
Biofármacos
Cardiología
Dermatología
Farmacia
Desarrollo de fármacos
Gestión de datos clínicos
Gestión de proyectos
Capacidad de análisis
Presentaciones técnicas
Oncology
Pharmaceutical Industry
Clinical Trials
CTMS
Clinical Development
Biotechnology
GCP
Regulatory Affairs
Pharmacovigilance
CRO
Lifesciences
ICH-GCP
Clinical Monitoring
EDC
Clinical Research
Diabetes
Therapeutic Areas
Sop
Regulatory Submissions
Market Access
HEOR
Patient Reported Outcomes
Industria farmacéutica
Desarrollo clínico
Organización de investigación por contrato
Ensayos clínicos
Oncología
Investigación clínica
Ciencias naturales
POE
Biotecnología
Control clínico
Sistema de gestión de ensayos clínicos
Normas ICH de buenas prácticas clínicas
Asuntos normativos
Buena práctica clínica
Captura de datos electrónica
Farmacovigilancia
See more
See less
Discover more about ADC TherapeuticsWhat is Neus Domper email address?
Email Neus Domper at [email protected] and [email protected]. This email is the most updated Neus Domper's email found in 2026.
What is Neus Domper phone number?
Neus Domper phone number is +41787709008.
How to contact Neus Domper?
To contact Neus Domper send an email to [email protected] or [email protected]. If you want to call Neus Domper try calling on +41787709008. (updated on April 10, 2025)
What company does Neus Domper work for?
Neus Domper works for ADC Therapeutics
What is Neus Domper's role at ADC Therapeutics?
Neus Domper is Director Clinical Development, Clinical Scientist
What industry does Neus Domper work in?
Neus Domper works in the Pharmaceuticals industry.
Neus Domper Email Addresses
Neus Domper Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Neus Domper
General Manager at Aware Fire Solutions
Director at John Lutge & Associated Pty Ltd
Bookkeeper and Office Manager at Robyn Chester Bookkeeping
Associate Director at ADC Therapeutics
Vice President at ADC Therapeutics
Associate Director, Commercial Downstream Manufacturing at ADC Therapeutics
Senior Director, Head of Data Management at ADC Therapeutics
Executive Director, Head of Marketing at ADC Therapeutics
Oncology Account Manager at Syndax Pharmaceuticals
Director IMP Product Quality at ADC Therapeutics
Associate Director-Talent Acquisition at ADC Therapeutics
Associate Director, Financial Planning & Analysis. at ADC Therapeutics
Hematology Therepeutic Specialist at ADC Therapeutics
Show more
Show less